Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nutrition 21 sales

This article was originally published in The Tan Sheet

Executive Summary

The Purchase, N.Y.-based nutritional bioscience company reports a 171% increase in total revenues to $12.7 mil. for the first quarter of its fiscal 2008. The performance is due in part to the "retail marketing and distribution plans" for Chromax, Iceland Health Maximum Strength Omega-3 and Diabetes Essentials, which are "achieving traction and delivering measurable results" with growth in major retail doors, the firm says. For example, the Chromax blood sugar supplement has expanded distribution by 6,000 sites in the past year for a total of 27,000 stores, the company notes. Nutrition 21's advertising and promotion expenses were up 141% from one year ago, related to the firm's expanding retail presence. Additionally, the company announced the launch of Core4Life Advanced Memory Formula for maintaining brain health; the product currently is available in two-thirds of the company's major retailers...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS101116

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel